ozempic.com
Link authority for ozempic.com (registrable domain: ozempic.com) from the Common Crawl web graph: PageRank and harmonic centrality history since 2017, current scores, and the site's top backlink sources.
Web-graph authority (0-100)
Domain scores measure ozempic.com as a whole: every subdomain's links rolled up into one node of Common Crawl's domain-level web graph. Host scores measure the exact hostname ozempic.com. WWW scores cover the www variant of that hostname, which the graph tracks as its own entry since January 2026 (before that, www and bare host were merged). A big gap between domain and host usually means the domain's authority lives on other subdomains. PageRank is link-endorsement authority: how much weight the sites linking here carry themselves. Harmonic centrality measures reach: how close this site sits to the rest of the web when following links, which favors broadly connected sites over ones boosted by a few heavy linkers. All are normalized 0 to 100 within each crawl snapshot; a dash means that series does not exist for this site.
Homepage
What ozempic.com presents on its own homepage: the page title, description, and the social share markup it publishes. Pulled from https://ozempic.com.
| Title | Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes |
|---|---|
| Description | Ozempic® (semaglutide) is a GLP-1 RA type 2 diabetes treatment that is available in an injectable pen or pill. Read Important Safety Information, including Boxed Warning. |
| OG Title | Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes |
| OG Description | Ozempic® (semaglutide) is a GLP-1 RA type 2 diabetes treatment that is available in an injectable pen or pill. Read Important Safety Information, including Boxed Warning. |
| Twitter Title | Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes |
| Twitter Card | summary_large_image |
Social accounts and contact points
Where this site maintains a presence and every reachable route its homepage exposes: social accounts, contact pages, addresses, and content feeds.
| Youtube | ozempic_semaglutide |
|---|---|
| ozempic_semaglutide | |
| Tiktok | ozempic_semaglutide |
| Youtube | ozempic_semaglutide_injection |
| ozempic_semaglutide_injection |
| Phones |
18663107549 18003321088 |
|---|
Structured data (JSON-LD)
The schema.org markup this homepage publishes: the machine-readable identity search engines and AI systems read. Types found: MedicalWebPage.
JSON-LD block (12,532 bytes)
{
"@context": "https://schema.org",
"@type": "MedicalWebPage",
"url": "https://www.ozempic.com/",
"name": "Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes",
"headline": "For adults with type 2 diabetes, along with diet and exercise, to improve blood sugar. Talk to your health care professional about which Ozempic® option is right for you.",
"description": "Ozempic® (semaglutide) is a GLP-1 RA type 2 diabetes treatment that is available in an injectable pen or pill. Read Important Safety Information, including Boxed Warning.",
"copyrightYear": 2026,
"copyrightHolder": {
"@type": "Organization",
"name": "Novo Nordisk",
"url": "https://www.novonordisk-us.com"
},
"audience": {
"@type": "MedicalAudience",
"audienceType": "Patient"
},
"about": [
{
"@type": "Drug",
"name": "Ozempic®",
"nonProprietaryName": "semaglutide",
"activeIngredient": "semaglutide",
"alternateName": [
"Ozempic® (semaglutide) injection",
"Ozempic® (semaglutide) tablets",
"Ozempic® pen",
"Ozempic® pill"
],
"drugClass": "GLP-1 (glucagon-like peptide-1) receptor agonist",
"dosageForm": [
"injection",
"tablets"
],
"administrationRoute": [
"subcutaneous injection",
"oral"
],
"doseSchedule": [
{
"@type": "DoseSchedule",
"frequency": "once-weekly",
"doseUnit": "mg",
"doseValue": [
0.5,
1,
2
],
"targetPopulation": "adults with type 2 diabetes"
},
{
"@type": "DoseSchedule",
"frequency": "once-daily",
"doseUnit": "mg",
"doseValue": [
4,
9
],
"targetPopulation": "adults with type 2 diabetes"
}
],
"availableStrength": [
{
"@type": "DrugStrength",
"strengthValue": 0.5,
"strengthUnit": "mg",
"activeIngredient": "semaglutide"
},
{
"@type": "DrugStrength",
"strengthValue": 1,
"strengthUnit": "mg",
"activeIngredient": "semaglutide"
},
{
"@type": "DrugStrength",
"strengthValue": 2,
"strengthUnit": "mg",
"activeIngredient": "semaglutide"
},
{
"@type": "DrugStrength",
"strengthValue": 4,
"strengthUnit": "mg",
"activeIngredient": "semaglutide"
},
{
"@type": "DrugStrength",
"strengthValue": 9,
"strengthUnit": "mg",
"activeIngredient": "semaglutide"
}
],
"prescriptionStatus": "https://schema.org/PrescriptionOnly",
"prescribingInfo": [
"https://www.novo-pi.com/ozempic.pdf",
"https://www.novo-pi.com/ozempictablets.pdf"
],
"warning": [
"Do not share your Ozempic® pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.",
"Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Ozempic® and medicines that work like Ozempic® caused thyroid tumors, including thyroid cancer. It is not known if Ozempic® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people"
],
"pregnancyWarning": "It is not known if Ozempic® will harm your unborn baby or pass into your breast milk. You should stop using Ozempic® at least 2 months before you plan to become pregnant",
"image": {
"@type": "ImageObject",
"name": "Ozempic® logo",
"contentUrl": "https://ozempic.com/content/dam/diabetes-patient/ozempic/images/25_01/header-combination-logo.png"
},
"manufacturer": {
"@type": "Organization",
"name": "Novo Nordisk Inc.",
"url": "https://www.novonordisk-us.com/home.html",
"contactPoint": {
"@type": "ContactPoint",
"contactType": "patient assistance",
"telephone": "1-866-310-7549",
"description": "Novo Nordisk provides patient assistance for those who qualify. Please call 1-866-310-7549 to learn more about Novo Nordisk assistance programs."
}
}
},
{
"@type": "MedicalCondition",
"name": "type 2 diabetes",
"alternateName": [
"diabetes"
]
},
{
"@type": "MedicalCondition",
"name": "heart disease",
"alternateName": [
"known heart disease",
"cardiovascular disease"
]
},
{
"@type": "MedicalCondition",
"name": "chronic kidney disease"
},
{
"@type": "MedicalTherapy",
"guideline": [
"Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg and Ozempic® (semaglutide) tablets 4 mg or 9 mg are prescription medicines used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes",
"Ozempic® injection is used to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes and known heart disease, to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease",
"Ozempic® tablets are used to reduce the risk if major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who are at high risk for these events"
],
"adverseOutcome": [
"The most common side effects of Ozempic® may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation.",
"inflammation of your pancreas (pancreatitis). Stop using Ozempic® and call your health care provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes may feel the pain from your abdomen to your back",
"changes in vision. Tell your health care provider if you have changes in vision during treatment with Ozempic®",
"low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Ozempic® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery",
"dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your health care provider right away if you have nausea, vomiting, or diarrhea that does not go away",
"severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Ozempic®. Tell your health care provider if you have stomach problems that are severe or will not go away",
"serious allergic reactions. Stop using Ozempic® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat",
"gallbladder problems. Gallbladder problems have happened in some people who take Ozempic®. Tell your health care provider right away if you get symptoms which may include: pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools",
"food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Ozempic® may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your health care providers that you are taking Ozempic® before you are scheduled to have surgery or other procedures"
],
"contraindication": [
"Do not use Ozempic® if: you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).",
"Do not use Ozempic® if: you have had a serious allergic reaction to semaglutide or any of the ingredients in Ozempic®."
],
"recognizingAuthority": {
"@type": "Organization",
"name": "U.S. Food and Drug Administration",
"alternateName": "FDA",
"url": "https://www.fda.gov/"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"item": {
"@id": "https://www.ozempic.com/",
"name": "Home"
}
}
]
},
"hasPart": [
{
"@type": "WebPageElement",
"headline": "For adults with type 2 diabetes, along with diet and exercise, to improve blood sugar",
"text": "Discover 2 ways to take Ozempic® and which uses may be right for you"
},
{
"@type": "WebPageElement",
"headline": "Only Novo Nordisk manufactures FDA-approved semaglutide medicines like Ozempic®"
},
{
"@type": "WebPageElement",
"headline": "For adults with type 2 diabetes, Ozempic® in a pen is the GLP-1 with the most FDA-approved uses. All uses may not apply. Ask your health care professional."
},
{
"@type": "WebPageElement",
"headline": "In adults with type 2 diabetes, Ozempic® in a pen lowers blood sugar and A1C, along with diet and exercise",
"potentialAction": {
"@type": "Action",
"name": "Learn about A1C",
"target": "https://ozempic.com/ozempic-pen/what-is-ozempic-pen.html#bloodSugar"
}
},
{
"@type": "WebPageElement",
"headline": "In adults who also have heart disease, Ozempic® in a pen lowers the risk of major cardiovascular events such as stroke, heart attack, or death",
"potentialAction": {
"@type": "Action",
"name": "Discover the impact",
"target": "https://ozempic.com/ozempic-pen/what-is-ozempic-pen.html#cardiovascular"
}
},
{
"@type": "WebPageElement",
"headline": "In adults who also have chronic kidney disease, Ozempic® lowers the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease",
"potentialAction": {
"@type": "Action",
"name": "Reduce your risk",
"target": "https://ozempic.com/ozempic-pen/what-is-ozempic-pen.html#kidney"
}
},
{
"@type": "WebPageElement",
"headline": "For adults with type 2 diabetes, Ozempic® pill is the only GLP-1 pill that lowers A1C and has a cardiovascular benefit.",
"potentialAction": {
"@type": "Action",
"name": "Lower your A1C",
"target": "https://www.ozempic.com/ozempic-pill/what-is-ozempic-pill.html"
}
},
{
"@type": "WebPageElement",
"headline": "Ozempic® pill lowers the risk of major cardiovascular events such as stroke, heart attack, or death, in adults with type 2 diabetes who are also at high risk for these events",
"potentialAction": {
"@type": "Action",
"name": "Lower your risk",
"target": "https://www.ozempic.com/ozempic-pill/what-is-ozempic-pill.html"
}
},
{
"@type": "WebPageElement",
"headline": "Watch the There's Only One Ozempic® campaign come to life alongside real patient stories.",
"potentialAction": {
"@type": "Action",
"name": "Learn more",
"target": "https://www.youtube.com/@ozempic_semaglutide_injection"
}
},
{
"@type": "WebPageElement",
"headline": "See how healthy eating can help you transform the way you manage your type 2 diabetes along with exercise.",
"potentialAction": {
"@type": "Action",
"name": "Learn more",
"target": "https://www.ozempic.com/lifestyle-tips/diet-and-exercise-tips.html"
}
}
]
}
Authority over time
Every Common Crawl web-graph release since 2017, roughly quarterly. The domain series goes back to 2017; Common Crawl only began publishing the host-level graph in 2020, so host lines start there. Click a legend entry to show or hide that line. Flat lines are normal for established sites; watch for sustained rises or drops, which track real gains or losses in who links here.
A note on www: through the end of 2025 the source web graph merged www and non-www hostnames into the bare name, so one host line covers both. Starting in January 2026 the graph splits them into separate entries, which is why www can carry its own scores going forward.
Backlink counts
Unique linking domains seen in Common Crawl's link graphs. This is a different dataset than the 0-100 authority scores above: these are raw counts, host-level for ozempic.com and domain-level for ozempic.com with all its subdomains combined. Common Crawl covers a large sample of the web, not all of it, so treat counts as comparable between sites rather than absolute totals.
Top backlinks in the domain graph
Common Crawl publishes two link graphs. The DOMAIN graph connects whole domains: every link from any page of one domain to any page of another. This table shows the highest-authority domains linking to ozempic.com (including its subdomains), ranked by the linker's PageRank. The table shows the top 1,000; the download carries the full stored list (up to 10,000 linkers) as JSON. Click a linker for its own site profile.
Top backlinks in the host graph
The HOST graph connects exact hostnames, so subdomains count separately. This table shows the highest-authority hosts linking to ozempic.com specifically, ranked by the linker's PageRank. The table shows the top 55; the download carries the full stored list (up to 10,000 linkers) as JSON. Click a linker for its own site profile.